Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 134Lung Neoplasms 50Adenocarcinoma of Lung 18Adenocarcinoma, Bronchiolo-Alveolar 10Brain Neoplasms 9NSCLC 8Neoplasms 5Neoplasm Metastasis 5Adenocarcinoma 4Respiratory Tract Diseases 3Carcinoma 3Thoracic Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Tongue Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1Recurrence 1Previous Treated Metastatic Non-small Cell Lung Cancer 1Pleural Effusion, Malignant 1Parathyroid Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1

Interventions

Cisplatin 8Carboplatin 8Bevacizumab 8Pleurodesis 7Talc 6Paclitaxel 6Docetaxel 5Povidone-Iodine 4Doxycycline 4Thoracoscopy 3Taxes 3Gemcitabine 3Drug Therapy 3Chest Tubes 3aldesleukin 2Zoledronic Acid 2Trastuzumab 2Thoracentesis 2Surveys and Questionnaires 2Sodium Chloride 2Silver Nitrate 2Pharmaceutical Preparations 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2High-Energy Shock Waves 2Fluorodeoxyglucose F18 2Fentanyl 2Erlotinib Hydrochloride 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion, Malignant × Gefitinib × Thoracic × Clear all
NCT00231465 2017-03-03

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
44 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡